New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses
Andrei E. Siniavin
, Vladimir A. Gushchin
, Natal'ya S. Shastina
, Elizaveta S. Darnotuk
, Sergey I. Luyksaar
, Leonid I. Russu
, Anna M. Inshakova
, Elena V. Shidlovskaya
, Daria V. Vasina
, Nadezhda A. Kuznetsova
, Daria M. Savina
, Ilya D. Zorkov
, Inna V. Dolzhikova
, Anna B. Sheremet
, Denis Y. Logunov
, Nailya A. Zigangirova
, Alexander L. Gintsburg
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses'. Together they form a unique fingerprint.
Keyphrases
Immunology and Microbiology
Pharmacology, Toxicology and Pharmaceutical Science